GLP-1 drugs like Ozempic and Wegovy are in high demand and short supply. The internet makes it easy for you to have a compounding pharmacy whip you up a batch—but should you?
Guest: Kate Knibbs, senior writer at Wired.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The Rise of Off-Brand Ozempic | What Next: TBD | Tech, power, and the future podcast - Listen or read transcript on Metacast
